Nick L. Occleston - Concepedia

Author

Nick L. Occleston

Moorfields Eye Hospital NHS Foundation Trust

Also Known As

N L Occleston, N. L. Occleston, N. Occleston, N.L. Occleston, Nick L Occleston, Nick L. Occleston, Nick Occleston, Nick. L. Occleston

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Moorfields Eye Hospital NHS Foundation Trust Renovo (United Kingdom)University College London Institute of Ophthalmology Moorfields Eye Hospital

About

Nick L. Occleston is an author at Moorfields Eye Hospital NHS Foundation Trust specializing in medicine, scar management, and scar prevention.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	381
2	Engineering	1	1	51
3	Biomedical Engineering	1	1	51
4	Immunology	1	1	16
5	Orthopaedics	1	1	51

Nick L. Occleston

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies Mark W. J. Ferguson, Jonathan Duncan, Jeremy S. Bond, The Lancet Scar ManagementCutaneous BiologyProphylactic AdministrationTopical DrugScar Prevention	2009	296
Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Chee Kon, Nick L. Occleston, G. William Aylward, PubMed	1999	173
Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity Philip Stephens, K.J. Davies, Nick L. Occleston, British Journal of Dermatology	2001	134
Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior. Nick L. Occleston, Julie T. Daniels, Roy Tarnuzzer, PubMed	1997	120
A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Chee Kon, Nick L. Occleston, David G. Charteris, PubMed	1998	98
Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring Nick L. Occleston, Sharon O’Kane, Hugh Laverty, Wound Repair and Regeneration	2011	78
Interleukin‐10 reduces scarring and enhances regeneration at a site of sciatic nerve repair Simon Atkins, Alison R. Loescher, Fiona M. Boissonade, Journal of the Peripheral Nervous System	2007	70
Effects of single exposures to antiproliferative agents on ocular fibroblast-mediated collagen contraction. Nick L. Occleston, Robert Alexander, Ank Mazure, PubMed	1994	63
Matrix Metalloproteinases Carl Sheridan, Nick L. Occleston, Paul Hiscott, American Journal Of Pathology	2001	58
Therapeutic Improvement of Scarring: Mechanisms of Scarless and Scar‐Forming Healing and Approaches to the Discovery of New Treatments Nick L. Occleston, Anthony D. Metcalfe, Adam Boanas, Dermatology Research and Practice Scar ManagementTissue EngineeringEngineeringSurgeryBiomedical Engineering	2010	51

Page 1